LEO, MARENZA
 Distribuzione geografica
Continente #
NA - Nord America 2.348
EU - Europa 882
AS - Asia 363
AF - Africa 60
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 3.666
Nazione #
US - Stati Uniti d'America 2.301
SE - Svezia 282
IT - Italia 187
CN - Cina 184
BG - Bulgaria 92
DE - Germania 90
SG - Singapore 82
GB - Regno Unito 73
CA - Canada 45
AT - Austria 42
FR - Francia 41
CI - Costa d'Avorio 38
VN - Vietnam 30
TR - Turchia 29
FI - Finlandia 22
IN - India 20
SN - Senegal 20
UA - Ucraina 16
BE - Belgio 12
HK - Hong Kong 11
RU - Federazione Russa 11
BR - Brasile 5
NL - Olanda 4
AU - Australia 3
EU - Europa 3
SA - Arabia Saudita 3
CH - Svizzera 2
LT - Lituania 2
PA - Panama 2
RO - Romania 2
BD - Bangladesh 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
HU - Ungheria 1
IE - Irlanda 1
JP - Giappone 1
PK - Pakistan 1
PL - Polonia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.666
Città #
Fairfield 288
Woodbridge 286
Houston 263
Ann Arbor 234
Chandler 158
Santa Clara 155
Ashburn 138
Seattle 132
Wilmington 103
Sofia 92
Cambridge 85
Serra 66
New York 56
Beijing 52
Singapore 49
Vienna 41
Abidjan 38
Ottawa 37
Princeton 37
London 35
Boardman 32
Lawrence 31
Medford 29
Bremen 26
Nanjing 24
Des Moines 23
Lancaster 23
Florence 22
Dakar 20
Dong Ket 18
Dearborn 15
Frankfurt am Main 15
Marseille 15
Ogden 15
Istanbul 14
Brussels 12
Fuzhou 12
Nanchang 10
San Diego 10
Falls Church 9
Hong Kong 9
Jacksonville 9
Pisa 9
Hebei 8
Izmir 8
Shanghai 8
Chicago 7
Toronto 7
Guangzhou 6
Kunming 6
Rome 6
Milan 5
Aosta 4
Changsha 4
Jüchen 4
Kent 4
Munich 4
Ossé 4
San Francisco 4
Tianjin 4
Boulder 3
Hangzhou 3
Helsinki 3
Jeddah 3
Jiaxing 3
Jinan 3
Manchester 3
Ningbo 3
Pesqueira 3
Redwood City 3
Vicopisano 3
Washington 3
Wuhan 3
Abano Terme 2
Ankara 2
Bucharest 2
Canberra 2
Chengdu 2
Conshohocken 2
Da Nang 2
Düsseldorf 2
Egg 2
Englewood 2
Gurgaon 2
Hefei 2
Hyderabad 2
Kocaeli 2
Los Angeles 2
New Delhi 2
Northbrook 2
Panama City 2
Phoenix 2
Queens 2
Senigallia 2
Taiyuan 2
Vertemate con Minoprio 2
Ambato 1
Auburn Hills 1
Central District 1
Council Bluffs 1
Totale 2.929
Nome #
Natural history of graves’ orbitopathy after treatment 178
A 70-year-old woman with Bilateral Orbital Infiltrative disease. 166
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 160
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 159
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 148
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 148
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 125
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 124
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 122
null 121
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 120
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 119
Dissecting the genetic susceptibility to graves' disease in a cohort of patients of Italian origin 116
Thyroid volume and severity of graves' orbitopathy 115
Treatment options for Graves' orbitopathy. 109
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 109
PREGO ( presentation of Graves' orbitopathy) study: Changes in referral patterns to European Group on Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012 107
Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves’ orbitopathy 104
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 104
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy 98
null 97
Combined mycophenolate + prednisolone therapy is more effective than prednisolone in active and moderate-to-severe Graves’ Orbitopathy – A randomized, observer blind, multicenter trial 94
null 93
null 91
null 88
Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial 87
Oxidative stress in graves' disease. 85
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy 85
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 78
Use of low-dose radioiodine ablation for Graves’ orbitopathy: results of a pilot, perspective study in a small series of patients 74
Selenium in Graves Hyperthyroidism and Orbitopathy 66
null 65
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study 65
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy 44
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 40
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 32
Total thyroid ablation in Graves' orbitopathy 15
Totale 3.751
Categoria #
all - tutte 10.695
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020418 0 0 0 0 0 86 80 66 72 41 56 17
2020/2021286 14 19 19 30 30 10 19 29 26 31 20 39
2021/2022516 5 8 6 38 110 59 9 17 75 63 11 115
2022/2023613 64 119 54 51 46 67 6 48 118 0 37 3
2023/2024269 13 20 31 5 30 71 7 20 4 3 37 28
2024/2025312 7 34 9 65 132 65 0 0 0 0 0 0
Totale 3.751